Thursday, April 29, 2021 at 12:00 PM
This grand round has already taken place.
April 29th, 2021 1.00 AMA PRA Category 1 Credit Hours
Description
In recent years, the role of immunosuppressive tumor microenvironment in tumor progression and therapeutic resistance has been widely accepted and thus, a great deal of efforts made to identify molecular targets to either eliminate immunosuppression or revert it to anti-tumorigenic microenvironment. Our research aims to understand the molecular mechanism and functional significance of tumor induced MDSCs in the formation of immunosuppressive tumor microenvironment and pre-metastatic niche formation.
Dates and Times
Start: 4/29/2021 12:00 PM
End: 4/29/2021 1:00 PM
Objectives
- How some breast tumors induce the differentiation of myeloid cells into an immunosuppressive myeloid derived suppressor cells (MDSCs) or tumor associated neutrophils (TAN).
- The contribution of MDSCs in establishment of tumor microenvironment and pre-metastatic niches.
- Therapeutic utility of targeting MDSCs in preclinical settings.
Speakers
Accreditation
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Nancy Strein
Department: Pathology
Phone: (631) 444-3000
Email: nancy.strein@stonybrookmedicine.edu